重型创伤性脑损伤后早期高氯血症与预后:复苏结局联盟高渗盐水试验分析
该研究为复苏结局联盟高渗盐水(ROC HS)-TBI试验的事后分析,纳入114个北美急救服务机构的991例格拉斯哥昏迷评分≤8分的重型TBI患者,院前随机接受单次静脉7.5%盐水+6%右旋糖酐-70、7.5%盐水(不含右旋糖酐)或晶体液复苏。以随机分组后24小时内血清氯≥110 mmol/L定义高氯血症,并按发生次数分级。校正混杂因素后,发生≥2次高氯血症者180天死亡或严重残疾的OR为1.81(95%CI 1.19-2.75),180天内死亡的OR为1.89(95%CI 1.14-3.08);但24小时总液体量是180天内死亡的独立预测因素,加入总液体量与≥2次高氯血症的交互项后,≥2次高氯血症者180天内死亡OR为2.35(95%CI 1.21-4.61),而复合终点不再显著。提示重型TBI早期反复高氯血症可能与180天死亡风险升高相关。
要点
- 991例重型TBI(GCS≤8)患者中,随机后24小时内血清氯≥110 mmol/L且发生≥2次者,校正混杂因素后180天死亡或严重残疾的OR为1.81(95%CI 1.19-2.75)。
- 同一组患者180天内死亡的OR为1.89(95%CI 1.14-3.08);但24小时总液体量是180天内死亡的独立预测因素。
- 加入24小时总液体量与≥2次高氯血症的交互项后,≥2次高氯血症者180天内死亡OR为2.35(95%CI 1.21-4.61),而180天死亡或严重残疾复合终点不再显著。
- 高氯血症定义为随机分组后24小时内血清氯≥110 mmol/L,并按24小时内发生1次或≥2次进行分级。
适用人群与场景
- 年龄及纳入标准未在本文中完整列出;研究对象为重型创伤性脑损伤且格拉斯哥昏迷评分≤8分的患者,来自复苏结局联盟高渗盐水(ROC HS)-TBI试验。
- 场景为院前复苏,由114个北美急救服务机构参与。
诊断标准与关键阈值
- 高氯血症定义为随机分组后24小时内血清氯浓度≥110 mmol/L。
- 高氯血症按24小时内发生次数分级为1次或≥2次。
处置流程与药物剂量
- 院前复苏采用单次静脉剂量250 cc的7.5%盐水+6%右旋糖酐-70、7.5%盐水(不含右旋糖酐)或晶体液。
研究设计与关键结果
- 研究类型为ROC HS-TBI试验的事后分析;样本量991例,来自114个北美急救服务机构;人群为重型TBI且GCS≤8分的患者。
- 干预为院前单次静脉250 cc的7.5%盐水+6%右旋糖酐-70、7.5%盐水(不含右旋糖酐)或晶体液复苏。
- 与无高氯血症者相比,校正混杂因素后,24小时内≥2次高氯血症者180天死亡或严重残疾的OR为1.81(95%CI 1.19-2.75),180天内死亡的OR为1.89(95%CI 1.14-3.08)。
- 24小时总液体量是180天内死亡的独立预测因素;加入总液体量与≥2次高氯血症的交互项后,≥2次高氯血症者180天内死亡OR为2.35(95%CI 1.21-4.61),但180天死亡或严重残疾复合终点不再显著。
证据类型、等级与局限
- 证据类型为随机对照试验的事后分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于重型TBI(GCS≤8)患者,伤后24小时内血清氯≥110 mmol/L且发生≥2次高氯血症,可能与180天内死亡风险升高相关;该关联受24小时总液体量影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: To investigate the effect of the occurrence of early hyperchloremia on death or severe disability at 180 days in patients with severe traumatic brain injury (TBI).
DESIGN: Post hoc analysis of Resuscitation Outcomes Consortium Hypertonic Saline (ROC HS)-TBI trial.
SETTING: A total of 114 North American emergency medical services agencies in the ROC.
PATIENTS: A total of 991 patients with severe TBI and Glasgow Coma Scale score of less than or equal to 8.
INTERVENTIONS: Prehospital resuscitation with single IV dose (250 cc) of 7.5% saline in 6% dextran-70, 7.5% saline (no dextran), or crystalloid.
MEASUREMENTS AND MAIN RESULTS: Patients with increased serum chloride concentrations (110 mmol/L or greater) 24 hours after randomization were identified. Hyperchloremia was graded into one or greater than or equal to 2 occurrences in the first 24 hours. Logistic regression analyses were performed to determine the effects of hyperchloremia on: 1) death or severe disability at 180 days and 2) death within 180 days after adjusting for confounders. Compared with patients without hyperchloremia, patients with greater than or equal to 2 occurrences of hyperchloremia had significantly higher odds of death or severe disability at 180 days (odds ratio [OR], 1.81; 95% CI, 1.19-2.75) and death within 180 days (OR, 1.89; 95% CI, 1.14-3.08) after adjustment for confounders. However, the total volume of fluids administered during the first 24 hours was an independent predictor of death within 180 days; therefore, after adding an interaction term between the total volume of fluids administered during the first 24 hours and greater than or equal to 2 occurrences of hyperchloremia, patients with greater than or equal to 2 occurrences of hyperchloremia had significantly higher odds of death within 180 days (OR, 2.35; 95% CI, 1.21-4.61 d) but not of composite outcome of death or severe disability at 180 days.
CONCLUSIONS: After modifying for the effect of the total volume of fluids administered during the first 24 hours, multiple occurrences of hyperchloremia in the first 24 hours were associated with higher odds of death within 180 days in patients with severe TBI.
参考来源
- Qureshi AI, Ma X, Huang W, et al. Early Hyperchloremia and Outcomes After Severe Traumatic Brain Injury: Analysis of Resuscitation Outcomes Consortium Hypertonic Saline Trial. Crit Care Explor. 2022. PMID: 36506832. doi:10.1097/CCE.0000000000000797
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。